Clinical trial
Evaluation of a Donor Testing Kit for the Prediction of Acute GVHD in Patient Receiving a Peripheral Blood Stem Cells Allograft- Predictor 2
NCT03887156 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Donor Testing Kit for the Prediction of Acute GVHD in Patient Receiving a Peripheral Blood Stem Cells Allograft- Predictor 2
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- September 16, 2019
- Completion date
- March 16, 2023
- Enrollment
- 227 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia biphenotypic in remission, acute lymphoblastic leukemia, acute myeloid leukemia in remission, lymphoma in remission, myelodysplasia with stable blasts is cell number and < 10% of blastocysts, non-progressive myeloproliferative syndrome